Xingli Zhou

7PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsAllergyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 17, 2025
Human urine-derived stem cells rescue cutaneous manifestation and suppress inflammation and fibrosis in vitro and in a mouse model of recessive dystrophic epidermolysis bullosa.

Xingli Zhou, Jie Tan, Yuting Song

|Jan 31, 2024
Ofatumumab subcutaneous injection successfully treated patients with pemphigus vulgaris relapse post rituximab.

Xiwen Zhang, Yue Xiao, Xiaohong Li

|Sep 19, 2023
Novel compound heterozygous mutations of the COL7A1 gene in a Chinese patient with recessive dystrophic epidermolysis bullosa pruriginosa and digestive symptoms successfully treated with tofacitinib.

Xingli Zhou, Jia Geng, Minjin Wang

|Jun 21, 2023
Anti-laminin γ1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone.

Xingli Zhou, Yuxi Zhou, Hua Qian

|Dec 06, 2021
Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study.

Xingli Zhou, Liangliang Cheng, Yiyi Wang

|Aug 31, 2021
Identification of novel compound heterozygous ITGB4 mutations in a Chinese woman with junctional epidermolysis bullosa without pylori atresia but profound urinary symptoms: A case report and review of the literature.

Xingli Zhou, Mi Wang, Sheng Wang

Pageof 2

Frequent Collaborators

7 joint publications

Wei Li

2 joint publications

Yuxi Zhou

1 joint publications

Xiaoguang Li

1 joint publications

Xiwen Zhang